unknown
Stage
About
ImmuneSpec provides immunopeptidomics (MHC-associated peptide proteomics, MAPPs) laboratory services to identify presented peptides for immunogenicity risk assessment, target discovery (including neoantigen discovery) and construct validation. Their services support biotherapeutic development, vaccine design and immuno-oncology research.
Explore ImmuneSpec's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.